Point of Care Molecular Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2021-2027

The Global Point of Care Molecular Diagnostics Market size is expected to grow at an annual average of 13% during 2021-2027. Molecular diagnostics have been carried out in centralized laboratories for many years. However, several drawbacks such as delayed results, high test cost, low accuracy, and late disease diagnosis increase mortality and hinder the growth of this market.

The following Segmentation are covered in this report:

Market, by Product & Service

• Assays & Kits
• Instruments/Analyzers
• Services & Software

Market, by Application

• Respiratory diseases
• STDs
• HAIs
• Oncology
• Hepatitis
• Other Applications

Market, by Technology

• RT-PCR
• INAAT
• Others Technologies

Market, by End User

• Physician Offices
• Hospital Emergency Departments & Intensive Care Units
• Research Institutes
• Other End User

Scope of the Report

The research study analyses the global Point of Care Molecular Diagnostics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

• Market Overview and growth analysis
• Import and Export Overview
• Volume Analysis
• Current Market Trends and Future Outlook
• Market Opportunistic and Attractive Investment Segment

Geographic Coverage

• North America Market Size and/or Volume
• Latin America Market Size and/or Volume
• Europe Market Size and/or Volume
• Asia-Pacific Market Size and/or Volume
• Rest of the world Market Size and/or Volume

Key Questions Answered by Point of Care Molecular Diagnostics Market Report

• What was the Point of Care Molecular Diagnostics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
• What will be the CAGR of Point of Care Molecular Diagnostics Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2018? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Point of Care Molecular Diagnostics Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.